Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b ...

Eli Lilly and Co. (NYSE:LLY) on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial ...

Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.

Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and overweight or obesity, according to topline results announced by Eli ...

Eli Lilly (NYSE:LLY) reported successful results from the TOGETHER-PsO Phase 3b trial combining Taltz and Zepbound for ...

New findings indicate that in adults with moderate-to-severe plaque psoriasis who are overweight or obese, combined treatment with ixekizumab (Taltz) and tirzepatide (Zepbound) results ...

Many of the professionals associated with Freiburg weren’t involved in the 2022 DFB Pokal Final shootout at Berlin’s Olympiastadion. That didn’t necessarily mean there wasn’t a sense of deja ...

Rep. Justin J. Pearson, local groups oppose xAI's permit for 41 gas turbines ...

Join our free webinar for a quick tour around ch-aviation with an introduction to its Business Aviation data & news and best practices for a flying start.

There have been many shocking finishes in the history of the Daytona 500, but there's nothing quite like what went down in ...

The move, formalised by Army Headquarters, comes shortly after Prime Minister Tarique Rahman’s government assumed office on ...